Vycor Medical, Inc. (VYCO)

Market Cap	2.34M -41.1%
Revenue (ttm)	1.86M +17.2%
Net Income	-396.80K
EPS	-0.01
Shares Out	33.42M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,000
Average Volume	19,831
Open	0.0699
Previous Close	n/a
Day's Range	0.0699 - 0.0699
52-Week Range	0.0321 - 0.5000
Beta	-0.41
RSI	38.18
Earnings Date	May 12, 2026

About Vycor Medical

Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates through two segments: Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation targeted at people who have impaired vision as a result of stroke or other brain injury. It has a license agreement with a ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 7
• Stock Exchange: OTCMKTS
• Ticker Symbol: VYCO

Financial Performance

In 2025, Vycor Medical's revenue was $1.86 million, an increase of 17.24% compared to the previous year's $1.59 million. Losses were -$396,796, -8.06% less than in 2024.